Faculty News

Prof. Aswath Damodaran on the risk of investing in tech IPOs

Excerpt from The Wall Street Journal -- "'Investors think about how big the diabetes drug market is, see a company offering a diabetes drug, and say, "Let me make a bet on this,"' [Damodaran] says. 'There are going to be a couple winners. But no one knows who.'"

Read more